We are live on ! Find out more
TWST icon

Twist Bioscience

236 hedge funds and large institutions have $3.96B invested in Twist Bioscience in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 81 increasing their positions, 73 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more capital inflows, than outflows

Capital inflows: $546M | Capital outflows: $227M

11% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 73

4.53% more ownership

Funds ownership: 98.72% → 103.25% (+4.5%)

2% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 42

0% less funds holding

Funds holding: 237 → 236 (-1)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

46% less call options, than puts

Call options by funds: $8.03M | Put options by funds: $14.8M

Holders
236
Holders Change
-1
Holders Change %
-0.42%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
43
Increased
81
Reduced
73
Closed
42
Calls
$8.03​M
Puts
$14.8​M
Net Calls
-⁠$6.79​M
Net Calls Change
-⁠$13.1​M

TWST Hedge Fund Activity: Q4 2021 in Review

236 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2021, worth a combined $3.96B — down 24% from $5.2B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new TWST positions and 42 closed out — a net gain of 1 holder — while 81 added to existing stakes and 73 trimmed.

The largest buyer was Ardevora Asset Management, opening a new position worth an estimated $71.8M. The largest seller was Casdin Capital, cutting an estimated $33.9M.

  • 236 institutional investors held Twist Bioscience (TWST) as of Q4 2021, down from 237 in Q3 2021.
  • Funds reported $3.96B of Twist Bioscience stock for Q4 2021, down 24% quarter-over-quarter.
  • 43 funds opened new Twist Bioscience positions in Q4 2021 and 42 closed out, a net change of +1 holder.
  • The largest Twist Bioscience buyer in Q4 2021 was Ardevora Asset Management, an estimated $71.8M added.
  • The largest Twist Bioscience seller in Q4 2021 was Casdin Capital, an estimated $33.9M sold.

Based on aggregated 13F filings for Q4 2021.